Complementary medicines: Rheumatoid arthritis

0
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by joint inflammation. The immune system attacks the tissue lining the joints (synovial membrane), causing...

Cost of asthma treatment – a deterrent to use

0
Cost is a major factor associated with non-adherence to asthma treatment in Australia, recent research revealed. Healthcare providers can assist patients with adherence by...

Pharmacist on the rise

0
Ayomide Ogundipe’s initiative, commitment to patient-centred care, and leadership while interning at Pharmacy777 in Perth has earned her PSA’s Intern of the Year award. Ms...

PSA National President opening address at PSA24

0
Read the transcript of the speech delivered by PSA National President Associate Professor Fei Sim FPS at PSA24 today (2 August).

Ethical lessons for Australian pharmacists from overseas

0
What ethical lessons do Australian pharmacists need to heed from other countries? A panel of experts at the FIP Congress filled in the blanks.

Ensuring safer opioid systems

0
Opioid analgesic stewardship is now a national medicines safety priority, targeting preventable harm across acute settings and transitions to community care.